This review evaluates the antihypertensive potential of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1RA), particularly in patients with comorbid diabetes, HF, CKD or resistant hypertension
The inhibitory effects of melittin and BV on c-Jun N-terminal kinases (JNK) signaling were observed at concentrations of 5 g/mL and within a range of 0.15 g/mL, respectively
117 Neutrophils rolling at high shear rates of blood require rapid adhesive formation and disruption, and the dissociation of the P-selectin-PSGL1 bond at the trailing edge of the cell must be counterbalanced by the formation of a different bond at the leading edge
However, several clinical studies have shown that GLP-1 intervention did not improve hepatic steatosis in NAFLD patients 18,19
Importantly, long-term BSO treatment did not substantially affect mouse body weight (Fig
Medically reviewed by Oghenefejiro Okifo | MD , Harvard Medical School | Henry Ford Hospital - Detroit, MI on October 29th, 2025
